Generate a tailored SOP for Dr. Sara Cherry. Improve your application with a focused, well-structured draft.
Sara Cherry is a prominent researcher in the field of biomedical science, with a focus on the genetic mechanistic studies of viral-host interactions. Her laboratory utilizes advanced chemical genetic screening technologies to explore the complex relationships between viruses and their hosts, specifically investigating emerging viruses such as coronaviruses and arboviruses. The Cherry Lab performs a wide array of cell-based screens using human and insect cells, contributing significantly to understanding innate immunity and antiviral defense mechanisms. Her research includes examining the roles of RNA binding proteins and RNA decay machinery in the immune response to various RNA viruses. Additionally, her team has been involved in projects that assess how dysbiosis impacts susceptibility to infections and the influence of microbiota on intestinal responses to viral infections. In light of the recent coronavirus pandemic, Dr. Cherry's work has expanded to include screening for antiviral activity of various drugs and understanding innate pathways that control SARS-CoV-2 infection in respiratory cells. Furthermore, her collaborations with oncologists and pathologists aim to personalize treatment strategies for patients suffering from acute myelogenous leukemia and other malignancies.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.